Nicotine Dependence (Tobacco Use Disorder)

Nicotine Dependence, formally Tobacco Use Disorder in DSM-5, is a problematic pattern of tobacco or nicotine use leading to clinically significant impairment or distress, encompassing traditional smoking, smokeless tobacco, and increasingly, vaping. It is one of the most common and most lethal substance use disorders globally, given tobacco's well-established link to numerous serious diseases.

Tobacco Use Disorder is defined by a problematic pattern of tobacco use leading to clinically significant impairment or distress, manifested by two or more of eleven criteria within a 12-month period — a structure similar to other substance use disorders, covering impaired control, social impairment, risky use, tolerance, and withdrawal. Severity is specified as mild, moderate, or severe.

Nicotine is highly and rapidly addictive, reaching the brain within seconds of inhalation and strongly activating the dopamine reward pathway. Genetic factors influence nicotine metabolism rate and addiction vulnerability, and early initiation — particularly during adolescence, when the developing brain is especially sensitive to nicotine's effects on reward circuitry — strongly predicts later dependence. Social and environmental factors, including family and peer smoking and advertising exposure, also contribute significantly.

• Early age of first use, particularly during adolescence
• Family history of nicotine dependence
• Co-occurring mental health conditions — smoking rates are notably higher in depression, schizophrenia, and other psychiatric conditions
• Peer or family smoking
• Lower socioeconomic status
• Genetic variants affecting nicotine metabolism

Nicotine binds to nicotinic acetylcholine receptors, triggering dopamine release in the mesolimbic reward pathway within seconds of use. With repeated use, the brain upregulates the number of nicotinic receptors as a compensatory response, which paradoxically increases the 'need' for nicotine to feel normal and drives withdrawal symptoms when nicotine levels drop — explaining the classic pattern of needing a cigarette shortly after waking and cravings between uses.

• Strong urges or cravings to use tobacco
• Unsuccessful efforts to cut down or quit
• Significant time spent using tobacco
• Tolerance
• Withdrawal symptoms when not using — irritability, anxiety, difficulty concentrating, increased appetite, restlessness, depressed mood
• Continued use despite knowledge of harmful physical consequences
• Giving up activities that conflict with tobacco use, such as avoiding smoke-free environments

• Two or more of eleven criteria within a 12-month period
• Causes significant distress or impairment
• Severity specified as mild, moderate, or severe

Conditions a psychiatrist will consider and rule out before confirming this diagnosis:

Occasional/social tobacco use

Without meeting the specific dependence criteria threshold.

Other substance use disorders

Frequently co-occur, particularly alcohol use disorder.

Primary psychiatric disorders

May drive self-medication with nicotine, notably in schizophrenia and depression, where nicotine may transiently affect certain symptoms, complicating cessation efforts.

• Clinical interview and detailed tobacco use history (pack-years, pattern, prior quit attempts)
• Fagerström Test for Nicotine Dependence
• Screening for co-occurring substance use and psychiatric conditions
• Assessment of tobacco-related health complications where clinically relevant

A combination of behavioral counseling and pharmacotherapy is more effective than either alone. Nicotine replacement therapy and prescription medications (varenicline, bupropion) are first-line pharmacological options, and setting a specific quit date with structured behavioral support significantly improves success rates compared to unassisted quitting.

Nicotine Replacement Therapy (patches, gum, lozenges, inhalers, nasal spray)

Reduces withdrawal symptoms by providing controlled nicotine without the other harmful components of tobacco smoke.

Varenicline

Partially stimulates nicotine receptors while blocking the full rewarding effect of smoking; among the most effective single medications.

Bupropion

An antidepressant that also reduces nicotine cravings and withdrawal, useful particularly with co-occurring depression.

Behavioral/cessation counseling

Individual or group counseling focused on quitting.

Motivational Interviewing

For those ambivalent about quitting.

Cognitive Behavioral Therapy

Addresses triggers and relapse prevention.

Quitline/telephone counseling

Widely available and evidence-based support.

• Set a specific quit date
• Identify and plan for personal smoking triggers
• Remove smoking-associated items and environments where possible
• Use nicotine replacement or medication as prescribed, rather than relying on willpower alone
• Tell others about the quit attempt to build a support network
• Prepare for the possibility of needing multiple quit attempts before achieving lasting cessation

Nicotine dependence is highly treatable, though multiple quit attempts are often needed before achieving lasting cessation — a normal, expected part of the process, not a sign of failure. Combination pharmacotherapy and behavioral support significantly improve long-term quit rates, and health benefits of quitting begin within hours to days and continue to accrue for years.

• Preventing initiation, particularly during adolescence
• Tobacco control policies: taxation, advertising restrictions, smoke-free environments
• School and community-based prevention programs
• Addressing co-occurring mental health conditions that increase smoking risk

Support quit attempts without excessive pressure or shaming, which can increase stress and paradoxically trigger smoking. Understand that relapse during a quit attempt is common and should be met with encouragement to try again. Help create a smoke-free home environment, and be patient with temporary mood changes or irritability during nicotine withdrawal.

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR).
2. World Health Organization Framework Convention on Tobacco Control.
3. U.S. Surgeon General reports on smoking cessation.